Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X.
作者信息
Taqueti Viviany R, Ridker Paul M
出版信息
JACC Cardiovasc Imaging. 2013 Jun;6(6):668-71. doi: 10.1016/j.jcmg.2013.02.005.
Abstract
摘要
相似文献
1
Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X.炎症、冠状动脉血流储备与微血管功能障碍：超越心脏X综合征
JACC Cardiovasc Imaging. 2013 Jun;6(6):668-71. doi: 10.1016/j.jcmg.2013.02.005.
2
Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease.炎症和微血管功能障碍在心脏 X 综合征患者中，这些患者没有冠状动脉疾病的传统危险因素。
JACC Cardiovasc Imaging. 2013 Jun;6(6):660-7. doi: 10.1016/j.jcmg.2012.12.011. Epub 2013 May 1.
3
Reappraisal of Ischemic Heart Disease.缺血性心脏病再评估。
Circulation. 2018 Oct 2;138(14):1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373.
4
Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X.心脏 X 综合征中心血管危险因素与冠状动脉微血管功能障碍的关系。
J Cardiovasc Med (Hagerstown). 2011 May;12(5):322-7. doi: 10.2459/JCM.0b013e3283406479.
5
Ischemia with normal coronary arteries: a puzzle and an opportunity.冠状动脉正常的缺血：一个谜题与一次机遇。
J Cardiovasc Med (Hagerstown). 2011 May;12(5):309-10. doi: 10.2459/JCM.0b013e32834588fe.
6
Microvascular dysfunction: What have we learned from WISE?微血管功能障碍：我们从WISE研究中学到了什么？
Expert Rev Cardiovasc Ther. 2011 Dec;9(12):1491-4. doi: 10.1586/erc.11.165.
7
Inflammation: a possible pathogenic link to cardiac syndrome X.炎症：与心脏X综合征可能的致病联系。
Med Hypotheses. 2006;66(1):87-91. doi: 10.1016/j.mehy.2005.08.005. Epub 2005 Sep 21.
8
9
Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease.胸痛且冠状动脉无阻塞的患者中心血管功能障碍的患病率。
JACC Cardiovasc Interv. 2015 Sep;8(11):1445-1453. doi: 10.1016/j.jcin.2015.06.017.
10
Aortic Stiffness Is Associated with Coronary Microvascular Dysfunction in Patients with Non-obstructive Coronary Artery Disease.在非阻塞性冠状动脉疾病患者中，主动脉僵硬度与冠状动脉微血管功能障碍相关。
Intern Med. 2020;59(23):2981-2987. doi: 10.2169/internalmedicine.5401-20. Epub 2020 Dec 1.
引用本文的文献
1
Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study.达格列净治疗2型糖尿病患者4年后冠状动脉血流储备增加：DAPAHEART随访研究
Cardiovasc Diabetol. 2025 Aug 31;24(1):351. doi: 10.1186/s12933-025-02912-4.
2
Cardiovascular Disease from Pathophysiology to Risk Estimation: Is Inflammation Estimated through Perivascular Attenuation on Computed Tomography the Key?从病理生理学到风险评估的心血管疾病：通过计算机断层扫描上的血管周围衰减估计炎症是关键吗？
Life (Basel). 2024 Mar 29;14(4):457. doi: 10.3390/life14040457.
3
Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure.身体成分、冠状动脉微血管功能障碍与未来心血管事件（包括心力衰竭）风险。
JACC Cardiovasc Imaging. 2024 Feb;17(2):179-191. doi: 10.1016/j.jcmg.2023.07.014. Epub 2023 Sep 27.
4
Relationship of OCT-defined plaque characteristics with CCTA-derived coronary inflammation and CMR-derived global coronary flow reserve in patients with acute coronary syndrome.光学相干断层扫描（OCT）定义的斑块特征与急性冠状动脉综合征患者的 CCTA 衍生的冠状动脉炎症和 CMR 衍生的整体冠状动脉血流储备的关系。
PLoS One. 2023 May 25;18(5):e0286196. doi: 10.1371/journal.pone.0286196. eCollection 2023.
5
Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial.冠状动脉血流储备、炎症与心肌应变：CIRT-CFR试验
JACC Basic Transl Sci. 2022 Dec 21;8(2):141-151. doi: 10.1016/j.jacbts.2022.08.009. eCollection 2023 Feb.
6
Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.根据冠状动脉微血管功能障碍，非阻塞性冠状动脉疾病中的缺血的临床相关性。
J Am Heart Assoc. 2022 May 3;11(9):e025171. doi: 10.1161/JAHA.121.025171. Epub 2022 Apr 27.
7
Inflammation in Metabolic Cardiomyopathy.代谢性心肌病中的炎症
Front Cardiovasc Med. 2021 Oct 4;8:742178. doi: 10.3389/fcvm.2021.742178. eCollection 2021.
8
Physiological significance of pericoronary inflammation in epicardial functional stenosis and global coronary flow reserve.心外膜功能性狭窄和整体冠状动脉血流储备的冠状周围炎症的生理意义。
Sci Rep. 2021 Sep 24;11(1):19026. doi: 10.1038/s41598-021-97849-5.
9
Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms.冠状动脉微血管功能障碍与射血分数保留心力衰竭——慢性炎症机制的影响。
Curr Cardiol Rev. 2022;18(2):e310821195986. doi: 10.2174/1573403X17666210831144651.
10
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study.C反应蛋白血液滤过术作为急性心肌梗死的抗炎治疗：CAMI-1研究结果
Front Cardiovasc Med. 2021 Mar 10;8:591714. doi: 10.3389/fcvm.2021.591714. eCollection 2021.
本文引用的文献
1
Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease.炎症和微血管功能障碍在心脏 X 综合征患者中，这些患者没有冠状动脉疾病的传统危险因素。
JACC Cardiovasc Imaging. 2013 Jun;6(6):660-7. doi: 10.1016/j.jcmg.2012.12.011. Epub 2013 May 1.
2
Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.慢性肾脏病患者的冠状动脉血管功能障碍与预后。
JACC Cardiovasc Imaging. 2012 Oct;5(10):1025-34. doi: 10.1016/j.jcmg.2012.06.007.
3
Association between serum total antioxidant status and coronary microvascular functions in patients with SLE.系统性红斑狼疮患者血清总抗氧化状态与冠状动脉微血管功能之间的关联
Echocardiography. 2012 Nov;29(10):1218-23. doi: 10.1111/j.1540-8175.2012.01797.x. Epub 2012 Aug 29.
4
Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus.冠心病患者和非糖尿病患者冠状动脉功能障碍与心脏死亡率的关系。
Circulation. 2012 Oct 9;126(15):1858-68. doi: 10.1161/CIRCULATIONAHA.112.120402. Epub 2012 Aug 23.
5
Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma.冠状动脉微血管功能障碍与薄帽纤维粥样瘤的发生频率较高有关。
Atherosclerosis. 2012 Aug;223(2):384-8. doi: 10.1016/j.atherosclerosis.2012.05.034. Epub 2012 Jun 19.
6
Impaired coronary flow reserve in young patients affected by severe psoriasis.年轻重症银屑病患者的冠状动脉血流储备受损。
Atherosclerosis. 2012 Mar;221(1):113-7. doi: 10.1016/j.atherosclerosis.2011.12.015. Epub 2011 Dec 22.
7
Endothelial dysfunction as assessed by flow-mediated dilation in patients with cardiac syndrome X: role of inflammation.心脏 X 综合征患者的血流介导扩张评估的内皮功能障碍：炎症的作用。
Eur Rev Med Pharmacol Sci. 2011 Sep;15(9):1074-7.
8
Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.非侵入性冠状动脉血流储备测量可改善心脏风险评估。
Circulation. 2011 Nov 15;124(20):2215-24. doi: 10.1161/CIRCULATIONAHA.111.050427. Epub 2011 Oct 17.
9
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).白细胞介素-1β 抑制与复发性心血管事件的预防：卡那奴单抗抗炎血栓结局研究（CANTOS）的原理和设计。
Am Heart J. 2011 Oct;162(4):597-605. doi: 10.1016/j.ahj.2011.06.012. Epub 2011 Sep 14.
10
Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.铷-82 正电子发射断层成像显示的心肌血流储备受损可预测评估心肌缺血患者的不良预后。
J Am Coll Cardiol. 2011 Aug 9;58(7):740-8. doi: 10.1016/j.jacc.2011.01.065.
Zotero 插件